Related by context. Frequent words. (Click for all words.) 89 XIENCE V vs. 73 0 len = 72 0 document.write 70 elements.length 69 events MACE 69 confidence interval #.#-#.# 69 & s2 = 68 CI #.#-#.# [002] 68 placebo p = 67 plus dexamethasone 67 systemic embolism 67 target lesion revascularization 66 Taxus Stent 66 J Am Coll 66 OS = ISD/#/#/# 65 % #lt ;/ 65 tirofiban 65 nonfatal myocardial infarction 65 g trans fats 65 grams saturated 64 annualized relapse 64 Exacta £ 64 mg kg belimumab 64 placebo p 64 lispro 64 #.# SPOT GOLD 64 8 Cyl 64 & co1 = 64 MARKETS EUROPE STOCKS 64 % #gt 64 % CI #.#-#.# [007] 64 CI -#.# 63 grams dietary fiber 63 * FLOOD STAGE 63 plus prednisone 63 6 Cyl 63 repeat revascularization 63 venous thromboembolic events 63 var i 63 target vessel revascularization 63 THE STAGE WAS 62 Arch Intern Med 62 leukopenia 62 febrile neutropenia 62 TAXUS Stent 62 myocardial infarction stroke 62 cardiovascular hospitalization 62 plus methotrexate 62 nasopharyngitis 62 primary hypercholesterolemia 62 severe renal impairment 62 % CI #.#-#.# [003] 62 chlorambucil 62 Technical Downtrend Reversal 62 g saturated 62 + + className 62 NYHA Class II 62 Off Magazines 62 patients undergoing percutaneous 62 cerebrovascular events 62 mmol l 61 Chronic Heart Failure 61 Secondary endpoints included 61 confidence interval CI 61 duration mediaQueryString 61 P = .# 61 - -Schwenkler 61 achieved statistical significance 61 Montgomery Asberg Depression 61 irbesartan 61 g dl 61 By Thomas Gryta 61 #.# Baht Reporting 61 eplerenone 61 Its ROA 61 % CI #.#-#.# [006] 61 fraction LVEF 60 statistically significant p = 60 plus gemcitabine 60 Acute Coronary Syndromes 60 Additional Downside 60 mg QD 60 Nephrol 60 OPERATING MARGIN 60 #,# BID PRICE 60 narrower DJ Stoxx 60 J Am Podiatr 60 Technical Uptrend Continuation 60 cytogenetic response 60 discontinuations due 60 paclitaxel eluting stents 60 ximelagatran 60 Lactic acidosis 60 SMARTREND WATCHING FOR 60 mEq L 60 patients receiving ERBITUX 59 undergoing coronary artery 59 DOXIL 59 CI = 59 Engerix B 59 thromboembolic events